Selective Estrogen Receptor Modulators
This graph shows the total number of publications written about "Selective Estrogen Receptor Modulators" by people in the URMC Research Network by year, and whether "Selective Estrogen Receptor Modulators" was a major or minor topic of these publication.
Below are the most recent publications written about "Selective Estrogen Receptor Modulators" by people in Profiles.
-
Hautmann AH, Elad S, Lawitschka A, Greinix H, Bertz H, Halter J, Faraci M, Hofbauer LC, Lee S, Wolff D, Holler E. Metabolic bone diseases in patients after allogeneic hematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease. Transpl Int. 2011 Sep; 24(9):867-79.
-
Patel A, Puzas E, Baumhauer J. Practical osteoporosis management: topical review. Foot Ankle Int. 2010 Apr; 31(4):354-60.
-
Archer DF, Lewis V, Carr BR, Olivier S, Pickar JH. Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal women. Fertil Steril. 2009 Sep; 92(3):1039-44.
-
Zhang Y, Sieuwerts AM, McGreevy M, Casey G, Cufer T, Paradiso A, Harbeck N, Span PN, Hicks DG, Crowe J, Tubbs RR, Budd GT, Lyons J, Sweep FC, Schmitt M, Schittulli F, Golouh R, Talantov D, Wang Y, Foekens JA. The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy. Breast Cancer Res Treat. 2009 Jul; 116(2):303-9.
-
Pandya KJ, Thummala AR, Griggs JJ, Rosenblatt JD, Sahasrabudhe DM, Guttuso TJ, Morrow GR, Roscoe JA. Pilot study using gabapentin for tamoxifen-induced hot flashes in women with breast cancer. Breast Cancer Res Treat. 2004 Jan; 83(1):87-9.
